Racial differences in premenopausal endogenous hormones

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 9, 2005, Pages 2147-2153

  Pinheiro, Simone P ^a,b   Holmes, Michelle D ^b   Pollak, Michael N ^c   Barbieri, Robert L ^b   Hankinson, Susan E ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GROWTH FACTOR; PROGESTERONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN AMERICAN; BREAST CANCER; CALCULATION; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREMENOPAUSE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RACE DIFFERENCE;

ADULT; AFRICAN AMERICANS; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GONADAL STEROID HORMONES; HUMANS; PREMENOPAUSE; REGRESSION ANALYSIS; RISK FACTORS; SOMATOMEDINS;

EID: 27744539496     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0944     Document Type: Article

References (78)

1. Furberg H, Millikan R, Dressler L, Newman B, Geradts J. Tumor characteristics in African American and White women. Breast Cancer Res Treat 2001;68:33-43.
2. Middleton LP, Chen V, Perkins GH, Pinn V, Page D. Histopathology of breast cancer among African-American women. Cancer 2003;97:253-7.
3. Newman LA, Burner S, Carolin K, et al. Ethnicity related differences in the survival of young breast carcinoma patients. Cancer 2002;95:21-7.
4. Ries L, Kosary C, Hankey B, Miller B, Clegg L, Edwards B (eds.). SEER cancer statistics review, 1973-1996. Bethesda: National Cancer Institute; 1999.
5. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993;85:1819-27.
6. Adami H, Hunter D, Trichopoulos D. Textbook of cancer epidemiology. New York: Oxford University Press; 2002.
7. Parkin DM. The global burden of cancer. Semin Cancer Biol 1998;8:219-35.
8. Deepen D, Liu L, Perkins C, Bernstein L, Ross RK. Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer 2002;99:747-50.
9. Hulka BS, Stark AT. Breast cancer: cause and prevention. Lancet 1995;346:883-7.
10. Prall OW, Rogan EM, Sutherland RL. Estrogen regulation of cell cycle progression in breast cancer cells. J Steroid Biochem Mol Biol 1998;65:169-74.
11. Thomas T, Thomas TJ. Regulation of cyclin B1 by estradiol and polyamines in MCF-7 breast cancer cells. Cancer Res 1994;54:1077-84.
12. Nandi S, Guzman RC, Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci U S A 1995;92:3650-7.
13. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
14. Thomas HV, Key TJ, Allen DS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer 1997;76:401-5.
15. Marshman E, Streuli CH. Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function. Breast Cancer Res 2002;4:231-9.
16. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-53.
17. LeRoith D, Roberts CT, Jr. The insulin-like growth factor system and cancer. Cancer Lett 2003;195:127-37.
18. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993;341:938-41.
19. Bianchini F, Kaaks R, Vainio H. Weight control and physical activity in cancer prevention. Obes Rev 2002;3:5-8.
20. Welsch CW, Nagasawa H. Prolactin and murine mammary tumorigenesis: a review. Cancer Res 1977;37:951-63.
21. Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma. Endocr Rev 2003;24:1-27.
22. Ormandy CJ, Hall RE, Manning DL, et al. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. J Clin Endocrinol Metab 1997;82:3692-9.
23. Hankinson SE, Willett WC, Michaud DS, et al. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1999;91:629-34.
24. Rockhill B, Willett WC, Hunter DJ, et al. Physical activity and breast cancer risk in a cohort of young women. J Natl Cancer Inst 1998;90:1155-60.
25. Lenton EA, Landgren BM, Sexton L. Normal variation in the length of the luteal phase of the menstrual cycle: identification of the short luteal phase. Br J Obstet Gynaecol 1984;91:685-9.
26. Lenton EA, Landgren BM, Sexton L, Harper R. Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age. Br J Obstet Gynaecol 1984;91:681-4.
27. Hankinson SE, London SJ, Chute CG, et al. Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem 1989;35:2313-6.
28. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-6.
29. Endogenous Hormones and Breast Cancer Collaborative Group. Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values. Cancer Epidemiol Biomarkers Prev 2003;12:1457-61.
30. SAS Institute Inc., Cary NC, USA. 1999.
31. Haiman CA, Pike MC, Bernstein L, et al. Ethnic differences in ovulatory function in nulliparous women. Br J Cancer 2002;86:367-71.
32. Woods MN, Barnett JB, Spiegelman D, et al. Hormone levels during dietary changes in premenopausal African-American women. J Natl Cancer Inst 1996;88:1369-74.
33. Henderson BE, Bernstein L, Ross RK, Depue RH, Judd HL. The early in utero oestrogen and testosterone environment of Blacks and Whites: potential effects on male offspring. Br J Cancer 1988;57:216-8.
34. Pham KT, Grisso JA, Freeman EW. Ovarian aging and hormone replacement therapy. Hormonal levels, symptoms, and attitudes of African-American and White women. J Gen Intern Med 1997;12:230-6.
35. Richards RJ, Svec F, Bao W, Srinivasan SR, Berenson GS. Steroid hormones during puberty: racial (Black-White) differences in androstenedione and estradiol: the Bogalusa Heart Study. J Clin Endocrinol Metab 1992;75:624-31.
36. Sowers M, Crawford SL, Cauley JA, Stein E. Association of lipoprotein(a), insulin resistance, and reproductive hormones in a multiethnic cohort of pre- and perimenopausal women (The SWAN Study). Am J Cardiol 2003;92:533-7.
37. Shimizu H, Ross RK, Bernstein L, Pike MC, Henderson BE. Serum oestrogen levels in postmenopausal women: comparison of American Whites and Japanese in Japan. Br J Cancer 1990;62:451-3.
38. Key TJ, Chen J, Wang DY, Pike MC, Boreham J. Sex hormones in women in rural China and in Britain. Br J Cancer 1990;62:631-6.
39. Probst-Hensch NM, Pike MC, McKean-Cowdin R, Stanczyk FZ, Kolonel LN, Henderson BE. Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight. Br J Cancer 2000;82:1867-70.
40. Randolph JF, Jr., Sowers M, Gold EB, et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 2003;88:1516-22.
41. Hill P, Wynder EL, Helman P, Hickman R, Rona G, Kuno K. Plasma hormone levels in different ethnic populations of women. Cancer Res 1976;36:2297-301.
42. Hill P, Chan P, Cohen L, Wynder E, Kuno K. Diet and endocrine-related cancer. Cancer 1977;39:1820-6.
43. Bulbrook RD, Swain MC, Wang DY, et al. Breast cancer in Britain and Japan: plasma oestradiol-17β, oestrone and progesterone and their urinary metabolites in normal British and Japanese women. Bur J Cancer 1976;12:725-35.
44. Wang DY, Key TJ, Pike MC, Boreham J, Chen J. Serum hormone levels in British and rural Chinese females. Breast Cancer Res Treat 1991;181 Suppl 1:S41-5.
45. Bernstein L, Yuan JM, Ross RK, et al. Serum hormone levels in premenopausal Chinese women in Shanghai and White women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes Control 1990;1:51-8.
46. Dickinson LE, MacMahon B, Cole P, Brown JB. Estrogen profiles of Oriental and Caucasian women in Hawaii. N Engl J Med 1974;291:1211-3.
47. MacMahon B, Cole P, Brown JB, et al. Oestrogen profiles of Asian and North American women. Lancet 1971;2:900-2.
48. MacMahon B, Cole P, Brown JB, et al. Urine oestrogen profiles of Asian and North American women. Int J Cancer 1974;14:161-7.
49. Lipworth L, Hsieh CC, Wide L, et al. Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer 1999;79:7-12.
50. Eden J. Progestins and breast cancer. Am J Obstet Gynecol 2003;188:1123-31.
51. Soderqvist G. Effects of sex steroids on proliferation in normal mammary tissue. Ann Med 1998;30:511-24.
52. Moorman PG, Kuwabara H, Millikan RC, Newman B. Menopausal hormones and breast cancer in a biracial population. Am J Public Health 2000;90:966-71.
53. Gambrell RD, Jr., Maier RC, Sanders BI. Decreased incidence of breast cancer in postmenopausal estrogen-progesterone users. Obstet Gynecol 1983;62:435-43.
54. Santen RJ, Pinkerton J, McCartney C, Petroni GR. Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy. J Clin Endocrinol Metab 2001;86:16-23.
55. Bush TL, Whiteman M, Flaws JA. Hormone replacement therapy and breast cancer: a qualitative review. Obstet Gynecol 2001;98:498-508.
56. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
57. Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 2000;92:328-32.
58. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000;283:485-91.
59. Ukkola O, Gagnon J, Rankinen T, et al. Age, body mass index, race and other determinants of steroid hormone variability: the HERITAGE Family Study. Eur J Endocrinol 2001;145:1-9.
60. Helzlsouer KJ, Alberg AJ, Bush TL, et al. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 1994;18:79-85.
61. Wang DY, De Stavola BL, Bulbrook RD, et al. Relationship of blood prolactin levels and the risk of subsequent breast cancer. Int J Epidemiol 1992;21:214-21.
62. Hayward JL, Greenwood FC, Glober G, et al. Endocrine status in normal British, Japanese and Hawaiian-Japanese women. Eur J Cancer 1978;14:1221-8.
63. Karey KP, Sirbasku DA. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 β-estradiol. Cancer Res 1988;48:4083-92.
64. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
65. Pollak M, Costantino J, Polychronakos C, et al. Effect of tamoxifen on serum insulin-like growth factor I levels in stage I breast cancer patients. J Natl Cancer Inst 1990;82:1693-7.
66. Ellis MJ, Jenkins S, Hanfelt J, et al. Insulin-like growth factors in human breast cancer. Breast Cancer Res Treat 1998;52:175-84.
67. Sugumar A, Liu YC, Xia Q, Koh YS, Matsuo K. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Cancer 2004;111:293-7.
68. Maskarinec G, Williams AE, Kaaks R. A cross-sectional investigation of breast density and insulin-like growth factor I. Int J Cancer 2003;107:991-6.
69. Wright NM, Papadea N, Willi S, et al. Demonstration of a lack of racial difference in secretion of growth hormone despite a racial difference in bone mineral density in premenopausal women: a Clinical Research Center study. J Clin Endocrinol Metab 1996;81:1023-6.
70. Shibata A, Harris DT, Billings PR. Concentrations of estrogens and IGFs in umbilical cord blood plasma: a comparison among Caucasian, Hispanic, and Asian-American females. J Clin Endocrinol Metab 2002;87:810-5.
71. DeLellis K, Ingles S, Kolonel L, et al. IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br J Cancer 2003;88:277-82.
72. Girgis R, Abrams SA, Castracane VD, Gunn SK, Ellis KJ, Copeland KC. Ethnic differences in androgens, IGF-I and body fat in healthy prepubertal girls. J Pediatr Endocrinol Metab 2000;13:497-503.
73. Yanovski JA, Sovik KN, Nguyen TT, Sebring NG. Insulin-like growth factors and bone mineral density in African American and White girls. J Pediatr 2000;137:826-32.
74. Wong WW, Copeland KC, Hergenroeder AC, Hill RB, Stuff JE, Ellis KJ. Serum concentrations of insulin, insulin-like growth factor-I and insulin-like growth factor binding proteins are different between White and African American girls. J Pediatr 1999;135:296-300.
75. Platz EA, Pollak MN, Rimm EB, et al. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiol Biomarkers Prev 1999;8:1107-10.
76. Michaud DS, Manson JE, Spiegelman D, et al. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 1999;8:1059-64.
77. Moore JW, Clark GM, Takatani O, Wakabayashi Y, Hayward JL, Bulbrook RD. Distribution of 17 β-estradiol in the sera of normal British and Japanese women. J Natl Cancer Inst 1983;71:749-54.
78. Kaplan JB, Bennett T. Use of race and ethnicity in biomedical publication. Jama 2003;289:2709-16.